Skip to content

ARROWHEAD PHARMACEUTICALS, INC.: 10-Q filed 2014-05-06

What ARROWHEAD PHARMACEUTICALS, INC. reported in its quarterly report filed 2014-05-06 (fiscal Q2 2014): 33 published measures, 137 facts as tagged in accession 0001564590-14-001816.

This filing

Form
10-Q (quarterly report)
Filed
2014-05-06
Fiscal period
fiscal Q2 2014
Accession
0001564590-14-001816 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ARROWHEAD PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-03-31202,641,394USD
At 2013-09-3037,329,631USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-03-31191,399,034USD
At 2013-09-3027,498,666USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-03-31142,847,860USD
At 2013-09-3019,114,444USD
At 2013-03-313,313,483USD
At 2012-09-303,377,288USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-01-01 to 2014-03-31-13,942,521USD90
2013-10-01 to 2014-03-31-24,570,831USD182
2003-05-01 to 2014-03-31-190,547,840USD3988
2013-01-01 to 2013-03-31-6,757,937USD90
2012-10-01 to 2013-03-31-11,372,095USD182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-10-01 to 2014-03-31607,772USD182
2003-05-01 to 2014-03-314,949,961USD3988
2012-10-01 to 2013-03-3131,468USD182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-01-01 to 2014-03-3143,750USD90
2013-10-01 to 2014-03-3187,500USD182
2003-05-01 to 2014-03-314,516,600USD3988
2013-01-01 to 2013-03-3143,750USD90
2012-10-01 to 2013-03-31202,766USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-03-31-190,711,800USD
At 2013-09-30-166,140,969USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-03-313,290,270USD
At 2013-09-303,513,235USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-03-311,198,444USD90
2013-10-01 to 2014-03-311,719,582USD182
2003-05-01 to 2014-03-3116,837,321USD3988
2013-01-01 to 2013-03-31355,108USD90
2012-10-01 to 2013-03-31750,782USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-03-31-11,212,498USD90
2013-10-01 to 2014-03-31-18,221,880USD182
2003-05-01 to 2014-03-31-160,027,169USD3988
2013-01-01 to 2013-03-31-5,390,288USD90
2012-10-01 to 2013-03-31-10,200,308USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-03-31161,923,165USD
At 2013-09-3028,843,719USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-03-3110,482,540USD
At 2013-09-308,725,020USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-03-312,511,572USD
At 2013-09-301,199,632USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2014-03-3195,864USD
At 2013-09-30123,191USD
At 2012-09-301,667,247USD
At 2011-09-301,731,211USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-09-3075,000USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-01-01 to 2014-03-3111,256,248USD90
2013-10-01 to 2014-03-3118,309,380USD182
2003-05-01 to 2014-03-31164,543,769USD3988
2013-01-01 to 2013-03-315,434,038USD90
2012-10-01 to 2013-03-3110,403,074USD182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-01-01 to 2014-03-315,216,446USD90
2013-10-01 to 2014-03-318,349,460USD182
2003-05-01 to 2014-03-3159,673,835USD3988
2013-01-01 to 2013-03-312,125,019USD90
2012-10-01 to 2013-03-313,701,685USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-03-3151,867,071shares
At 2013-09-3032,489,444shares

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2014-03-31189,537,557USD
At 2013-09-3025,734,789USD
At 2012-09-308,808,909USD
At 2011-09-3012,564,167USD
At 2010-09-308,078,295USD
At 2009-09-304,857,936USD
At 2008-09-3012,302,609USD
At 2007-09-3026,456,577USD
At 2006-09-3031,605,644USD
At 2005-09-3028,026,657USD
At 2004-09-3011,227,149USD
At 2003-09-301,419,762USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2014-03-316,963,393USD
At 2013-09-306,594,421USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-03-313,673,123USD
At 2013-09-303,081,186USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2014-03-313,213,186USD
At 2013-09-303,240,513USD
At 2012-09-304,784,569USD
At 2011-09-301,731,211USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-03-311,755,520USD
At 2013-09-301,758,709USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2014-03-31913,856USD
At 2013-09-30638,884USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2014-01-01 to 2014-03-31-13,982,700USD90
2013-10-01 to 2014-03-31-24,668,431USD182
2003-05-01 to 2014-03-31-167,186,461USD3988
2013-01-01 to 2013-03-31-6,939,683USD90
2012-10-01 to 2013-03-31-11,720,391USD182

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2014-01-01 to 2014-03-31-13,982,700USD90
2013-10-01 to 2014-03-31-24,668,431USD182
2003-05-01 to 2014-03-31-210,024,869USD3988
2012-10-01 to 2013-09-30-31,703,433USD365
2013-01-01 to 2013-03-31-6,940,019USD90
2012-10-01 to 2013-03-31-11,720,745USD182
2011-10-01 to 2012-09-30-22,110,723USD366
2010-10-01 to 2011-09-30-3,492,399USD365
2009-10-01 to 2010-09-30-6,957,038USD365
2008-10-01 to 2009-09-30-19,308,392USD365
2007-10-01 to 2008-09-30-27,241,639USD366
2006-10-01 to 2007-09-30-30,712,947USD365
2005-10-01 to 2006-09-30-19,961,961USD365
2004-10-01 to 2005-09-30-6,733,427USD365
2003-10-01 to 2004-09-30-751,255USD366
2002-10-01 to 2003-09-30-95,238USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-01-01 to 2014-03-311,347,677USD90
2013-10-01 to 2014-03-312,261,461USD182
2003-05-01 to 2014-03-3137,103,540USD3988
2013-01-01 to 2013-03-31779,970USD90
2012-10-01 to 2013-03-311,697,646USD182

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2014-01-01 to 2014-03-31395,779USD90
2013-10-01 to 2014-03-31799,184USD182
2003-05-01 to 2014-03-319,959,882USD3988
2013-01-01 to 2013-03-31448,765USD90
2012-10-01 to 2013-03-31898,362USD182

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2013-10-01 to 2014-03-3127,327USD182
2012-10-01 to 2013-09-30236,009USD365
2011-10-01 to 2012-09-30293,964USD366

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2014-01-01 to 2014-03-3176,546USD90
2013-10-01 to 2014-03-3171,215USD182
2003-05-01 to 2014-03-31-676,760USD3988
2013-01-01 to 2013-03-31-1,279,881USD90
2012-10-01 to 2013-03-31-1,257,196USD182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-01-01 to 2014-03-31-2,770,202USD90
2013-10-01 to 2014-03-31-6,446,551USD182
2003-05-01 to 2014-03-31-7,159,292USD3988
2013-01-01 to 2013-03-31-1,549,395USD90
2012-10-01 to 2013-03-31-1,520,083USD182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2013-10-01 to 2014-03-31180,620,980USD182
2003-05-01 to 2014-03-31331,379,995USD3988
2014-02-23 to 2014-02-24112,600,000USD2
2013-10-10 to 2013-10-1160,000,000USD2
2012-10-01 to 2013-03-317,089,327USD182
2013-01-01 to 2013-01-313,500,000USD31
2012-12-01 to 2012-12-314,100,000USD31
2012-08-09 to 2012-08-106,200,000USD2

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2013-10-01 to 2014-03-311,311,947USD182
2003-05-01 to 2014-03-312,131,904USD3988
2012-10-01 to 2013-03-31-6,279USD182

Inspect the source

Entity
ARROWHEAD PHARMACEUTICALS, INC. / CIK 0000879407
Captured
2026-09-20T05:01:27.924Z
SEC response SHA-256
df8855dae0055b71bd49c85d7ebc47f72ea6d71536d6bfd857bed2fe95364863

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000879407.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))